Aromatase inhibitors as adjuvant therapies in patients with breast cancer

By Coombes R.C.   Gibson L.   Hall E.   Emson M.   Bliss J.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 309-311

Elsevier

Access to resources Recommend Favorite

Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators

By Geisler J.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 245-253

Elsevier

Access to resources Recommend Favorite

Breast cancer prevention-clinical trials strategies involving aromatase inhibitors

By Goss P.E.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 487-493

Elsevier

Access to resources Recommend Favorite

Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: preliminary report

By Chow L.W.C.   Wong J.L.N.   Toi M.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 443-447

Elsevier

Access to resources Recommend Favorite

Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings

By Ingle J.N.   Suman V.J.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 313-319

Elsevier

Access to resources Recommend Favorite